Ischaemic preconditioning: therapeutic implications for stroke?

Bibliography

• MURRY CE, JENNINGS RB, REIMER KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 74:1124–1236.
   PubMed Web of Science ®Google Scholar
• •This is the first report to describe the biological phenomenon of ischaemic preconditioning.
   Google Scholar
• BOLLI R: Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J. Ma Cell. Cardiol. (2001) 33:1897–1918.
   PubMed Web of Science ®Google Scholar
• NANDAGOPAL K, DAWSON TM, DAWSON VL: Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. Pharmacol Exp. Ther. (2001) 297:474–478.
   PubMed Web of Science ®Google Scholar
• CUTRN JC, PERRELLI MG, CAVALIERI B, PERALTA C, ROSELL CATAFOU J, POLI G: Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic. Biol. Med. (2002) 33:1200–1228.
   PubMed Web of Science ®Google Scholar
• BONVENTRE JV: Kidney ischemic preconditioning. CLIFF. Opin. Nephrol Hjpertens. (2002) 11:43–48.
   PubMed Web of Science ®Google Scholar
• BAKER CS, KUMAR S, RIMOLDI OE: Effects of brief ischemia and reperfusion on the myocardium and the role of nitric oxide. Heart Fail Rev (2003) 8:127–141.
   PubMedGoogle Scholar
• GROSS GJ, PEART JN: KNIT channels and myocardial preconditioning: an update. Am.Physiol. Heart ChM Physiol. (2003)285:H921–H930.
   Google Scholar
• •A review describing the role of KATp channels in myocardial preconditioning.
   Google Scholar
• MINNERS J, MCLEOD CJ, SACK MN: Mitochondrial plasticity in classical ischemic preconditioning - moving beyond the mitochondrial KATp channel. Cardiol Res. (2003) 59:1–6.
   Google Scholar
• JAESCHKE H: Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. I Physiol Gasmointest. Liver Physiol. (2003) 284:G15–G26.
   Google Scholar
• SELZNER N, RUDIGER H, GRAF R, CLAVIEN PA: Protective strategies against ischemic injury in the liver. Gastroenterology (2003) 125:917–936.
   PubMed Web of Science ®Google Scholar
• KITAGAWA K, MATSUMOTO M, TAGAYA M et al.: Ischemic tolerance phenomenon found in the brain. Brain Res. (1990) 528:21–24.
   PubMed Web of Science ®Google Scholar
• •This is the first report showing the neuroprotective effects of ischaemic tolerance.
   Google Scholar
• LJUNGGREN B, SCHUTZ H, SIESJO BK: Changes in energy state and acid-base parameters of the rat brain during complete compression ischemia. Brain Res. (1974) 73:277–289.
   PubMed Web of Science ®Google Scholar
• NOWAK TS, FRIED RL, LUST WD, PASS ONNEAU JV: Changes in brain energy metabolism and protein synthesis following transient bilateral ischemia in the gerbil. .1 Neurochem. (1985) 44:487–494.
   PubMed Web of Science ®Google Scholar
• KATO H, KOGURE K, NAKATA N, ARAKI T, ITOYAMA Y: Facilitated recovery from postischemic suppression of protein synthesis in the gerbil brain with ischemic tolerance. Thalia Res. Bull. (1995) 36:205–208.
   Google Scholar
• KIRINO T, TSUJITA Y, TAMURA A: Induced tolerance to ischemia in gerbil hippocampal neurons. Cereb. Blood Flow Metab. (1991) 11:299–307.
   PubMed Web of Science ®Google Scholar
• KITAGAWA K, MATSUMOTO M, KUWABARA K et al.: Ischemic tolerance phenomenon detected in various brain regions. Brain Res. (1991) 561:203–211.
   PubMed Web of Science ®Google Scholar
• CHEN T, KATO H, LIU XH, ARAKI T, ITOYAMA Y, KOGURE K: Ischemic tolerance can be induced repeatedly in the gerbil hippocampal neurons. Neurosci. Lett. (1994) 177:159–161.
   PubMedGoogle Scholar
• KITAGAWA K, MATSUMOTO M, MABUCHI T et al.: Ischemic tolerance in hippocampal CA1 neurons studied using contralateral controls. Neuroscience (1997) 81:989–998.
   PubMedGoogle Scholar
• KITAGAWA K, MATSUMOTO M, OHTSUKI T et al.: Extended neuronal protection induced after sublethal ischemia adjacent to the area with delayed neuronal death. Neuroscience (2000) 96:141–146.
   PubMedGoogle Scholar
• PEREZ-PINZON MA, XU GP, DIETRICH WD, ROSENTHAL M, SICK TJ: Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. Cereb. Blood Flow Metab. (1997) 17:175–182.
   PubMed Web of Science ®Google Scholar
• DOWDEN J, CORBET D: Ischemic preconditioning in 18- to 20-month-old gerbils. Stroke (1999) 30:1240–1246.
   PubMedGoogle Scholar
• •This study demonstrates IPC in aged animals, whereas most of the early studies were performed in young adult animals, which were hypothesised to be more susceptible to preconditioning than aged animals.
   Google Scholar
• GLAZIER SS, O'ROURKE DM, GRAHAM DI, WELSH FA: Induction of ischemic tolerance following brief focal ischemia in rat brain. I Cereb. Blood Flow Metab. (1994) 14:545–553.
   PubMedGoogle Scholar
• WU C, ZHAN RZ, QI S, FUJIHARA H, TAGA K, SHIM OJI K: A forebrain ischemic preconditioning model established in C57Black/Crj6 mice. Neurosci. Methods (2001) 107:101–106.
   PubMedGoogle Scholar
• RESHEF A, SPERLING O, ZOREF-SHANI E: Preconditioning of primary rat neuronal cultures against ischemic injury: characterization of the 'time window of protection.' Brain Res. (1996) 741:252–257.
   PubMedGoogle Scholar
• BRUER U, WEIH MK, ISAEV NK et al.: Induction of tolerance in rat cortical neurons: hypoxic preconditioning. FEBS Lett. (1997) 414:117–121.
   PubMedGoogle Scholar
• KASPEKOW L, SHAMLOO M, VICTOROW I, WIELOCH T: Sublethal in vitro glucose-oxygen deprivation protects neurons against a subsequent severe insult. Neuroreport (1998) 9:1273–1276.
   PubMedGoogle Scholar
• XU GP, DAVE KR, VIVERO R, SCHMIDT-KASTNER R, SICK TJ, PEREZ-PINZON MA: Improvement in neuronal survival after ischemic preconditioning in hippocampal slice cultures. Brain Res. (2002) 952:153–158.
   PubMedGoogle Scholar
• MACKAY KB, STIEFEL TH, FOSTER AC: Ischemic preconditioning reduces infarct volume after subdural hematoma in the rat. Brain Res. (2002) 930:200–205.
   PubMedGoogle Scholar
• CORBETT D, CROOKS P: Ischemic preconditioning: a long-term survival study using behavioral and histological endpoints. Brain Res. (1997) 760:129–136.
   PubMedGoogle Scholar
• OHNO M WATANABE S: Ischemic tolerance to memory impairment associated with hippocampal neuronal damage after transient cerebral ischemia in rats. Brain Res. Bull. (1996) 40:229–236.
   PubMedGoogle Scholar
• OHNO M, YAMAMOTO T, WATANABE S: Effects of intrahippocampal injections of N-methyl-D-aspartate receptor antagonists and scopolamine on working memory and reference memory assessed in rats by a three-panel runway task. Pbarinacol. Exp. The]: (1992) 263:943–950.
   PubMedGoogle Scholar
• KAWAI K, NAKAGOMI T, KIRINO T, TAMURA A, KAWAI N: Preconditioning in vivo ischemic inhibits anoxic long-term potentiation and functionally protects CA1 neurons in the gerbil. Cereb. Blood Flow Metab. (1998) 18:288–296.
   PubMedGoogle Scholar
• TAGA K, FUJIWARA N, SHIMOJI K: Ischemic tolerance preserves propagation of membrane depolarization. Neuroreport (2000) 11:2961–2964.
   PubMedGoogle Scholar
• FARRELL R, EVANS S, CORBETT D: Environmental enrichment enhances recovery of function but exacerbates ischemic cell death. Neuroscience (2001) 107:585–592.
   PubMed Web of Science ®Google Scholar
• ••Demonstration that environmentalenrichment can enhance functional recovery but paradoxically increases neuronal cell death.
   Google Scholar
• RIEPE MW, NIEMI WN, MEGOW D, LUDOLPH AC, CARPENTER DO: Mitochondrial oxidation in rat hippocampus can be preconditioned by selective chemical inhibition by succinate dehydrogenase. Exp. Neurol (1996a) 138:15–21.
   PubMedGoogle Scholar
• RIEPE MW, KASISCHKE K, GERICKE CA, LOWE A, HELLWEG R: Increase of hypoxic tolerance in rat hippocampal slices following 3-nitropropionic acid is not mediated by endogenous nerve growth factor. Neurosci. Lett. (1996b) 211:9–12.
   PubMedGoogle Scholar
• RIEPE MW, ESCLAIRE F, KASISCHKE K et al.: Increased hypoxic tolerance by chemic inhibition of oxidative phosphorylation: chemical preconditioning. Cereb. Blood Flow Metab. (1997) 17:257–264.
   PubMedGoogle Scholar
• AKETA S, NAKASE H, KAMADA Y, HIRAMASTU KI, SAKAKI T: Chemical preconditioning with 3-nitropropionic acid in gerbil hippocampal slices: therapeutic window and the participation of adenosine receptor. Exp. Neurol (2000) 166:385–391.
   PubMedGoogle Scholar
• MARUOKA N, MURATA T, OMATA N, FUJIBAYASHI Y, YONEKURA Y, WADA Y: Hypoxic tolerance induction in rat brain slices following 3-nitropropionic acid pretreatment as revealed by dynamic changes in glucose metabolism. NeuroscL Lett. (2002) 319:83–86.
   PubMedGoogle Scholar
• NAKAGAWA I, NAKASE H, AKETA S, KAMADA Y, YAMASHITA M, SAKAKI T: ATP-dependent potassium channel mediates neuroprotection by chemical preconditioning with 3-nitropropionic acid in gerbil hippocampus. Neurosci. Lett. (2002) 320:33–36.
   PubMed Web of Science ®Google Scholar
• WEIH M, BERGK A, ISAEV NK et al: Induction of ischemic tolerance in rat cortical neurons by 3-nitropropionic acid: chemical preconditioning. Neurosci. Lett. (1999) 272:207–210.
   PubMed Web of Science ®Google Scholar
• SUGINO T, NOZAKI K, TAKAGI Y, HASHIMOTO N: 3-nitropropionic acid induces ischemic tolerance in gerbil hippocampus in vivo. Neurosci. Lett. (1999) 259:9–12.
   PubMedGoogle Scholar
• GARNIER P, BERTRAND N, DEMOUGEOT C, PRIGENT-TESSIER A, MARIE C, BELEY A: Chemical preconditioning with 3-nitropropionic acid: lack of induction of neuronal tolerance in gerbil hippocampus subjected to transient forebrain ischemia. Brain Res. Bull. (2002) 58:33–39.
   PubMedGoogle Scholar
• KUROIWA T, YAMADA I, ENDO S, HAKAMATA Y, ITO U: 3-nitropropionic acid preconditioning ameliorates delayed neurological deterioration and infarction after transient focal cerebral ischemia in gerbils. Neurosci. Lett. (2000) 283:145–148.
   PubMedGoogle Scholar
• NAKASE H, HEIMANN A, URANISHI R, RIEPE MW, KEMPSKI O: Early-onset tolerance in rat global cerebral ischemia induced by a mitochondrial inhibitor. Neurosci. Lett. (2000) 290:105–108.
   PubMedGoogle Scholar
• HORIGUCHI T, KIS B, RAJAPAKSE N, SHIMIZU K, BUSIJA DW: Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke (2003) 34:1015–1020.
   PubMedGoogle Scholar
• GRABB MC, LOBNER D, TURETSKI DM, CHOI DW: Preconditioned resistance to oxygen-glucose deprivation-induced cortical neuronal death: alterations in vesicular GABA and glutamate release. Neuroscience (2002) 115:173–183.
   PubMedGoogle Scholar
• SOMMER C, FAHRNER A, KIESSLING M: Postischemic neuroprotection in the ischemic-tolerance state gerbil hippocampus is associated with increased ligand binding to inhibitory GAB-AA receptors. Acta Neuropathol (2003) 105:197–202.
   PubMedGoogle Scholar
• SOMMER C, FAHRNER A, KIESSLING M: PH] Muscimol binding to y-aminobutyric acidA receptors is upregulated in CA1 neurons of the gerbil hippocampus in the ischemia-tolerant state. Stroke (2002) 33: 1698-1705.
   Google Scholar
• XIE J, LU G, HOU Y: Role of excitatory amino acids in hypoxic preconditioning. Biol. Signals Recept. (1999) 8:267–274.
   PubMedGoogle Scholar
• YING HS, WEISHAUPT JH, GRABB M et al.: Sublethal oxygen-glucose deprivation alters hippocampal neuronal AMPA receptor expression and vulnerability to kainite-induced death. J. Neurosci. (1997) 17:9536–9544.
   PubMed Web of Science ®Google Scholar
• YAMAGUCHI K, YAMAGUCHI F, MIYAMOTO O, HATASE O, TOKUDA M: The reversible change of G1uR2 RNA editing in gerbil hippocampus in course of ischemic tolerance. Cereb. Blood Flow Metab. (1999) 19:370–375.
   PubMedGoogle Scholar
• ALSBO CW, WRANG ML, JOHANSEN FE DIEMER NH: Quantitative PCR analysis of AMPA receptor composition in two paradigms of global ischemia. Neuroreport (2000a) 11:311–315.
   PubMedGoogle Scholar
• ALSBO CW, WRANG ML, NIELSEN M, DIEMER NH: Ischemic tolerance affects the adenylation state of G1uR2 mRNA. Neuroreport (2000b) 11:3279–3282.
   PubMedGoogle Scholar
• KJOLLER C, DIEMER NH: G1uR2 protein synthesis and metabolism in rat hippocampus following transient ischemic and ischemic tolerance induction. Neurochern. mt. (2000) 37:7–15.
   PubMedGoogle Scholar
• ALSBO CW, WRANG ML, MOLLER F, DIEMER NH: Is the AMPA receptor subunit G1uR2 mRNA an early indicator of cell fate after ischemia? A quantitative single cell RT-PCR study. Brain Res. (2001) 894:101–108.
   PubMedGoogle Scholar
• SOMMER C, KIESSLING M: Ischemia and ischemic tolerance induction differentially regulate protein expression of G1uR1, G1uR2, and AMPA receptor binding protein in the gerbil hippocampus. G1uR2 (GluR-B) reduction does not predict neuronal death. Stroke (2002) 33:1093–1100.
   Google Scholar
• TANAKA H, CALDERONE A, JOVER T et al.: Ischemic preconditioning acts upstream of G1uR2 down-regulation to afford neuroprotection in the hippocampal CAl. Proc. Natl. Acad. Sci. USA (2002) 99:2362–2367.
   PubMed Web of Science ®Google Scholar
• CALDERONE A, JOVER T, NOH KM et al.: Ischemic insults derepress the gene silencer REST in neurons destined to die. Neurosci. (2003) 23:2112–2121.
   Google Scholar
• TAUSKELA JS, CHAKRAVARTHY BR, MURRAY CL et al.: Evidence from cultured rat cortical neurons of differences in the mechanism of ischemic preconditioning of brain and heart. Brain Res. (1999) 827:143–151.
   PubMedGoogle Scholar
• SHAMLOO M, WIELOCH T: Changes in protein tyrosine phosphorylation in the rat brain after cerebral ischemia in a model of ischemic tolerance. Cereb. Blood Flow Metab. (1999) 19:173–183.
   PubMed Web of Science ®Google Scholar
• BOND A, LODGE D, HICKS CA, WARD MA, O'NEILL MJ: NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischemic tolerance in the gerbil hippocampus. Eur: I Phannacol (1999) 380:91–99.
   PubMedGoogle Scholar
• GRABB M, CHOI DW: Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J. Neurosci. (1999) 19:1657–1662.
   PubMedGoogle Scholar
• TAUSKELA JS, HEWITT CK, MONETTE R: Cross-tolerance to otherwise lethal N-methyl-D-aspartate and oxygen-glucose deprivation in preconditioned cortical cultures. Neuroscience (2001) 107:571–584.
   PubMedGoogle Scholar
• SEMENOW DG, SAMOILOV MO, LAZARWICZ JW: Calcium transients in the model of rapidly induced anoxic tolerance in rat cortical slices: involvement of NMDA receptors. Neurosignals (2002) 11:329–335.
   PubMedGoogle Scholar
• RAVAL AP, DAVE KR, MOCHLY-ROSEN D, SICK TJ, PEREZ-PINZON MA: EPKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. Neurosci. (2003) 23:384–391.
   Google Scholar
• VAN WINKLE DM, THORNTON J, DOWNEY JM: Cardioprotection from ischemic preconditioning is lost following prolonged reperfusion in the rabbit. Coron. Artery Dis. (1991) 2:613–619.
   Web of Science ®Google Scholar
• TSUCHIDA A, YANG XM, BURCKHARTT B, MULLANE MK, COHEN MV, DOWNEY JM: Acadesine extends the window of protection afforded by ischemic preconditioning. Cardiovasc. Res. (1994) 28:379–383.
   PubMedGoogle Scholar
• MARBER MS, LATCHMAN DS, WALKER JM, YELLON DM: Cardiac stress protein elevation 24 hours following brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation (1993) 88:1264–1272.
   PubMed Web of Science ®Google Scholar
• YELLON DM, BASTER GF: A second window of protection or delayed preconditioning phenomenon: future horizons for myocardial protection? J. Ma Cell. Cardiol. (1995) 27:1023–1034.
   PubMed Web of Science ®Google Scholar
• •A review describing the delayed, longer-lasting window of protection induced by preconditioning.
   Google Scholar
• HEURTEAUX C, LAURITZEN I, WIDMANN C, LAZDUNSKI M: Essential role of adenosine, adenosine Al receptors, and ATP-sensitive K.' channels in cerebral ischemic preconditioning. Proc. Nati Acad. Sci. USA (1995) 92:4666–4670.
   PubMed Web of Science ®Google Scholar
• ••An excellent study describing therequirement of an adenosine signalling cascade in cerebral IPC.
   Google Scholar
• PLAMONDON H, BLONDEAU N, HEURTEAUX C, LAZDUNSKI M: Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and KATp channels. Cereb. Blood Flow Metab. (1999) 19:1296–1308.
   PubMedGoogle Scholar
• RESHEF A, SPERLING O, ZOREF-SHANI E: Opening of KATp channels is mandatory for acquisition of ischemic tolerance by adenosine. Neuroreport (2000) 11:463–465.
   PubMedGoogle Scholar
• CAPARRELLI DJ, CATTANEO SM, BETHEA BT et al.: Pharmacological preconditioning ameliorates neurological injury in a model of spinal cord ischemia. Ann. Thome. Surg. (2002) 74:838–844.
   PubMed Web of Science ®Google Scholar
• SHAKE JG, PECK EA, MARBAN E et al.:Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection. Ann. Thome. Surg. (2001) 72:1849–1854.
   PubMed Web of Science ®Google Scholar
• BLONDEAU N, WIDMANN C, LAZDUNSKI M, HEURTEAUX C: Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience (2002) 109:231–241.
   PubMed Web of Science ®Google Scholar
• •An interesting study describing the cellular relationship between KATp channels and polyunsaturated fatty acids.
   Google Scholar
• MUNOZ A, NAKAZAKI M, GOODMAN IC et al.: Ischemic preconditioning in the hippocampus of a knockout mouse lacking SUR1-based KNIT channels. Stroke (2003) 34:164–170.
   PubMedGoogle Scholar
• LIU D, LU C, WAN R, AUYEUNG WW, MATTSON MP: Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of bax translocation and cytochrome c release. Cereb. Blood Flow Metab. (2002) 22:431–443.
   PubMed Web of Science ®Google Scholar
• RESHEF A, SPERLING O, ZOREF-SHANI E: Preconditioning of primary rat neuronal cultures against ischemic injury: characterization of the time window of protection. Brain Res. (1996) 741:252–257.
   PubMedGoogle Scholar
• SIMS NR, ANDERSON MF: Mitochondrial contributions to tissue damage in stroke. Neurochein. Lir (2000) 40:511–526.
   Google Scholar
• KATAYAMA Y, MURAMATSU H, KAMIYA T, MCKEE A, TERASHI A: Ischemic tolerance phenomenon from an approach of energy metabolism and the mitochondrial enzyme activity of pyruvate dehydrogenase in gerbils. Brain Res. (1997) 746:126–132.
   PubMed Web of Science ®Google Scholar
• DAVE KR, SAUL I, BUSTO R, GINSBERG MD, SICK TI, PEREZ-PINZON MA: Ischemic preconditioning preserves mitochondrial function after global cerebral ischemia in rat hippocampus. I Cereb. Blood Flow Metab. (2001) 21:1401–1410.
   PubMed Web of Science ®Google Scholar
• ZHANG HX, DU GH, ZHANG IT: Ischemic preconditioning preserves brain mitochondrial functions during the middle cerebral artery occlusion in rat. Neurol. Res. (2003) 25:471–476.
   PubMedGoogle Scholar
• MATTSON MP: Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med. (2003) 3:65–94.
   PubMed Web of Science ®Google Scholar
• ••A number of cellular targets suitable fortherapeutic intervention in the treatment of neurodegenerative disorders are discussed in this review.
   Google Scholar
• SHIMAZAKI K, ISHIDA A, KAWAI N: Increase in bc1-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci. Res. (1994) 20:95–99.
   PubMed Web of Science ®Google Scholar
• BRAMBRINK AM, SCHNEIDER A, NOGA H et al.: Tolerance-inducing dose of 3-nitropropionic acid modulates bc1-2 and bax balance in the rat brain: a potential mechanism of chemical preconditioning. Cereb. Blood Flow Metab. (2000) 20:1425–1436.
   PubMedGoogle Scholar
• WADA K, MIYAZAWA T, NOMURA N et al.: Mn-SOD and bc1-2 expression after repeated hyperbaric oxygenation. Acta Neurochir. Suppl. (2000) 76:285–290.
   PubMedGoogle Scholar
• WU C, FUJIHARA H, YAO J et al: Different expression patterns of bc1-2, bcl-xl, and bax proteins after sublethal forebrain ischemia in C57Black/Crj6 mouse striatum. Stroke (2003) 34: 1803-1808.
   Google Scholar
• SHIMIZU S, NAGAYAMA T, JIN KL et al.: bc1-2 antisense treatment prevents induction of tolerance to focal ischemia in the rat brain. I Cereb. Blood Flow Metab. (2001) 21:233–243.
   PubMed Web of Science ®Google Scholar
• NAKATSUKA H, OHTA S, TANAKA J et al.: Cytochrome c release from mitochondria to the cytosol was suppressed in the ischemia-tolerance-induced hippocampal CA1 region after 5-minute forebrain ischemia in gerbils. Neurosci. Lett. (2000) 278:53–56.
   PubMed Web of Science ®Google Scholar
• ZHAN RZ, WU C, FUJIHARA H et al: Both caspase-dependent and caspase-independent pathways may be involved in hippocampal CA1 neuronal death because of loss of cytochrome c from mitochondria in a rat forebrain ischemia model. I. Cereb. Blood Flow Metab. (2001) 21:529–540.
   PubMed Web of Science ®Google Scholar
• ZHAN RZ, FUJIHARA H, BABA H, YAMAKURA T, SHIM 011 K: Ischemic preconditioning is capable of inducing mitochondrial tolerance in the rat brain. Anesthesiology (2002) 97:896–901.
   PubMed Web of Science ®Google Scholar
• QI S, ZHAN RZ, WU C et al: Sublethal cerebral ischemia inhibits caspase-3 activation induced by subsequent prolonged ischemia in the C57Black/Crj6 strain mouse. Neurosci. Lett. (2001) 315:133–136.
   PubMedGoogle Scholar
• MCLAUGHLIN BA, HARTNETT KA, ERHARDT IA et al.: Caspase 3 activation is essential for neuroprotection in preconditioning. Proc. Nati Acad. Sri. USA (2003) 100:715–720.
   PubMed Web of Science ®Google Scholar
• ••An excellent study describing the required activation of caspase-3 to induce neuroprotection following IPC.
   Google Scholar
• GARNIER P, YING W, SWANSON RA: Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1. Neurosci. (2003) 23:7967–7973.
   Google Scholar
• ••An excellent study describing therequirement of caspase-3 and the subsequent cleavage of PARP in IPC.
   Google Scholar
• MORI T, MURAMATSU H, MATSUI T, MCKEE A, ASANO T: Possible role of the superoxide anion in the development of neuronal tolerance following ischemic preconditioning in rats. Neuropathol. Appl. Neurobiol. (2000) 26:31–40.
   PubMedGoogle Scholar
• RAVATI A, AHLEMEYER B, BECKER A, KRIEGLSTEIN J: Preconditioning-induced neuroprotection is mediated by reactive oxygen species. Brain Res. (2000) 866:23–32.
   PubMed Web of Science ®Google Scholar
• LIU T, CLARK RK, MCDONNELL PC et al.: Tumor necrosis factor-a expression in ischemic neurons. Stroke (1994) 25:1481–1488.
   PubMed Web of Science ®Google Scholar
• BUTTINI M, APPEL K, SAUTER A, BEGICKE-HAERTER PJ, BODDEKE HW: Expression of tumor necrosis factor a after focal cerebral ischemia in the rat. Neuroscience (1996) 7:1–16.
   Google Scholar
• JEAN WC, SPELLMAN SR, MUSSBAUM ES, LOW WC: Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery (1998) 43:1382–1396.
   PubMed Web of Science ®Google Scholar
• TOUSANI O, BOUTIN H, CHUQUETJ, ROTHWELL N: Potential mechanisms of interleukin-1 involvement in cerebral ischemia. I Neuroinonunol. (1999) 100:203–215.
   PubMedGoogle Scholar
• BARONE FC, FEUERSTEIN GZ: Inflammatory mediators and stroke: new opportunities for novel therapeutics. Cereb. Blood Flow Metab. (1999) 19:819–834.
   PubMed Web of Science ®Google Scholar
• DOWNEN M, AMARAL TD, HUA LL, ZHAO ML, LEE SC: Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-a. Clia (1999) 28:114–127.
   Google Scholar
• STOLL G, JANDER S, SCHROETER M: Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv. Exp. Med. Biol. (2002) 513:87–113.
   PubMedGoogle Scholar
• LODDICK SA, ROTH WELL NJ: Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal ischemia in the rat. Cereb. Blood Flow Metab. (1996) 16:932–940.
   PubMed Web of Science ®Google Scholar
• RELTON JK, MARTIN D, THOMPSON RC, RUSSELL DA: Peripheral administration of interleukin receptor antagonist-1 inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol (1996) 138:206–213.
   PubMed Web of Science ®Google Scholar
• PROBERT L, AKASSOGLOU K, KASSIOTIS G, PASPARAKIS M, ALEXOPOULOU L, KOLLIAS G: TNF-a transgenic and knockout models of CNS inflammation and degeneration. Neuroiininunol (1997) 72:137–141.
   PubMed Web of Science ®Google Scholar
• OHTSUKI T, RUETZLER CA, TASAKI K, HALLENBECK JM: Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. I Cereb. Blood Flow Metab. (1996) 16:1137–1142.
   PubMed Web of Science ®Google Scholar
• LI X, WANG X: Application of real-time polymerase chain reaction for the quantitation of interleukin-113 mRNA upregulation in brain ischemic tolerance. Brain Res. Protoc. (2000) 5:211–217.
   PubMedGoogle Scholar
• WANG X, LI X, CURRIE RW, WILLETE RN, BARONE FC, FEUERSTEIN GZ: Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1I3 mRNA in ischemic brain tolerance.' Neurosci. Res. (2000) 59:238–246.
   Google Scholar
• BARONE FC, WHITE RE SPERA PA et al.: Ischemic preconditioning and brain tolerance: temporal histological and function outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist an early gene expression. Stroke (1998) 29:1937–1951.
   Google Scholar
• NAWASHIRO H, TASAKI K, RUETZLER CA, HALLENBECK JM: TNF-a pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. (1997) 17:483–490.
   PubMed Web of Science ®Google Scholar
• WANG X, LI X, ERHARDT JA, BARONE FC, FEUERSTEIN GZ: Detection of tumor necrosis factor-a mRNA induction in ischemic brain tolerance by means of real-time polymerase chain reaction.' Cereb. Blood Flow Metab. (2000) 20:15–20.
   PubMed Web of Science ®Google Scholar
• LIU J, GINIS I, SPATZ M, HALLENBECK JM: Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-a and ceramide. Am. I Physiol Cell Physiol (2000) 278:C144–C153.
   PubMed Web of Science ®Google Scholar
• GINIS I, JAISWAL R, KLIMANIS D, LIU J, GREENSPON J, HALLENBECK JM: TNF-a-induced tolerance to ischemic injury involves differential control of NF-icB transactivation: the role of NF-icB association with p300 adaptor. Cereb. Blood Flow Metab. (2002) 22:142–152.
   PubMed Web of Science ®Google Scholar
• KATO H, KOGURE K, ARAKI T, ITOYAMA Y: Astroglial and microglial reactions in the gerbil hippocampus with induced ischemic tolerance. Brain Res. (1994) 664:69–76.
   PubMedGoogle Scholar
• PEREZ-PINZON MA, VITRO TM, DIETRICH WD, SICK TJ: The effect of rapid preconditioning on the microglia, astrocytic, and neuronal consequences of global cerebral ischemia. Acta Neuropathol (1999) 97:495–501.
   PubMedGoogle Scholar
• KATO H, KOGURE K, ARAKI T, ITOYAMA Y: Graded expression of immunomolecules on activated microglia in the hippocampus following ischemia in a rat model of ischemic tolerance. Brain Res. (1995a)694:85–93.
   PubMed Web of Science ®Google Scholar
• KATO H, KOGURE K, ARAKI T, ITOYAMA Y: Induction of Jun-like immunoreactivity in astrocytes in gerbil hippocampus with ischemic tolerance. Neurosci. Lett. (1995b) 189:13–16.
   PubMed Web of Science ®Google Scholar
• LIU J, BARTELS M, LU A, SHARP FR: Microglia/macrophages proliferate in striatum and neocortex but not in hippocampus after brief global ischemia that produces ischemic tolerance in gerbil brain. Cereb. Blood Flow Metab. (2001) 21:361–373.
   PubMed Web of Science ®Google Scholar
• LESSMAN V, GOTTMANN K, MALCANGIO M: Neurotrophin secretion: current facts and future prospects. Frog. Neurobiol (2003) 69:341–374.
   Google Scholar
• ••An excellent review describing the currentfield of neurotrophic factors and their therapeutic utility.
   Google Scholar
• YAMAMOTO N, TAMADA A, MURAKAMI F: Wiring of the brain by a range of guidance cues. Frog. Neurobiol (2002) 68:393–407.
   Google Scholar
• KERSCHENSTEINER M, STADELMANN C, DECHANT G, WEKERLE H, HOHLFELD R: Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann. Neurol (2003) 53:292–304.
   PubMed Web of Science ®Google Scholar
• KRUTTGEN A, SAXENA S, EVANGELOPOULOS ME, WEIS J: Neurotrophins and neurodegenerative diseases: receptors stuck in traffic? Neuropathol Exp. Neurol (2003) 62:340–350.
   Google Scholar
• SAKAKI T, YAMADA K, OTSUKI H, YUGUCHI T, KOHMURA E, HAYAKAWA T: Brief exposure to hypoxia induces bEGF mRNA and protein and protects rat cortical neurons from prolonged hypoxic stress. Neurosci. Res. (1995) 23:289–296.
   PubMed Web of Science ®Google Scholar
• MATSUSHIMA K, HOGAN MJ, HAKIM AM: Cortical spreading depression protects against subsequent focal cerebral ischemia in rats. I Cereb. Blood Flow Metab. (1996) 16:221–226.
   PubMedGoogle Scholar
• MATSUSHIMA K, SCHMIDT-KASTNER R, HOGAN MJ, HAKIM AM: Cortical spreading depression activates trophic factor expression in neurons and astrocytes and protects against subsequent focal brain ischemia. Brain Res. (1998) 807:47–60.
   PubMed Web of Science ®Google Scholar
• TRUETTNERJ, BUSTO R, ZHAO W, GINSBERG MD, PEREZ-PINZON MA: Effect of ischemic preconditioning on the expression of putative neuroprotective genes in the rat brain. Brain Res. Ma Brain Res. (2002) 103:106–115.
   PubMedGoogle Scholar
• CHONG ZZ, KANG JQ, MAIESE K: Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. Cereb. Blood Flow Metab. (2002) 22:503–514.
   PubMedGoogle Scholar
• KONISHI Y, CHUI DH, HIROSE H, KUNISHITA T, TABIRA T: Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. (1993) 609:29–35.
   PubMed Web of Science ®Google Scholar
• TABIRA T, KONISHI Y, GALLYAS F: Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitro. Int. J. Dev. Neurarci (1995) 13:241–252.
   PubMedGoogle Scholar
• LING ZD, POTTER ED, LIPTON JW, CARVEY PM: Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp. Neurol (1998) 149:441–423.
   Google Scholar
• STUDER L, CSETE M, LEE SH et al.: Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. Neurosci. (2000) 20:7377–7383.
   Google Scholar
• SHINGO T, SOROKAN ST, SIMAZAKI T, WEISS S: Erythropoietin regulates the M vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. Neurosci. (2001) 21:9733–9743.
   Google Scholar
• LEE JY, KOH HC, CHANG MY, PARK CH, LEE YS, LEE SH: Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors. Neuroreport (2003) 14:1401–1404.
   PubMedGoogle Scholar
• MORISHITA E, MASUDA S, NAGAO M, YASUDA Y, SASAKI R: Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons and erythropoietin prevents M vitro glutamate-induced neuronal death. Neuroscience (1997) 76:105–116.
   PubMed Web of Science ®Google Scholar
• KAWAKAMI M, SEKIGUCHI M, SATO K, KOZAKI S, TAKAHASHI M: Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. Biol. Chem. (2001) 276:39469–39475.
   Google Scholar
• SINOR AD, GREENBERG DA: Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci. Lett. (2000) 290:213–215.
   PubMedGoogle Scholar
• LEWCZUK P, HASSELBLAT M, KAMROWSKI-KRUCK H et al: Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport (2000) 11:3485–3488.
   PubMedGoogle Scholar
• SAKANAKA M, WEN TC, MATSUDA S et al.: hi vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA (1998) 95:4635–4640.
   PubMed Web of Science ®Google Scholar
• BERNAUDIN M, MARTI HH, ROUSSEL S et al.: A potential role for erythropoietin in focal permanent cerebral ischemia in mice. Cereb. Blood Flow Metab. (1999) 19:643–651.
   PubMed Web of Science ®Google Scholar
• CALAPAI G, MARCIANO MC, CORICA F et al.: Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur. Pharmacol (2000) 401:349–356.
   PubMed Web of Science ®Google Scholar
• SIREN AL, FRATELLI M, BRINES M et al.: Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl Acad. Sci. USA (2001) 98:4044–4049.
   PubMed Web of Science ®Google Scholar
• WEN TC, SADAMOTO Y, TANAKA J et al.: Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bc1-xL expression. J. Neurosci. Res. (2002) 67:795–803.
   PubMed Web of Science ®Google Scholar
• BERNAUDIN M, TANG Y, REILLY M, PETIT E, SHARP FR: Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Biol. Chem. (2002) 277:39728–29738.
   Google Scholar
• RUSCHER K, FREYER D, KARSCH M et al.: Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an M vitro model. Neurosci. (2002) 22:10291–10301.
   Google Scholar
• PRASS K, RUSCHER K, KARSCH M et al.: Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and M vitro. I Cereb. Blood Flow Metab. (2002) 22:520–525.
   PubMed Web of Science ®Google Scholar
• PRASS K, SCHARFF A, RUSCHER K et al.: Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke (2003) 34:1981–1986.
   PubMed Web of Science ®Google Scholar
• MAULIK N, WATANABE M, ZU YL et al.: Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. (1996) 396:233–237.
   PubMed Web of Science ®Google Scholar
• HAQ SEA, CLERK A, SUGDEN PH: Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by adenosine in the perfused rat heart. FEBS Lett. (1998) 434:305–308.
   PubMedGoogle Scholar
• TAUSKELA JS, CHAKRAVARTHY BR, MURRAY CL et al.: Evidence from cultured rat cortical neurons of differences in the mechanism of ischemic preconditioning of brain and heart. Brain Res. (1999) 827:143–151.
   PubMedGoogle Scholar
• GONZALES-GULUETA M, FELDMAN AB, KLESSE LJ et al: Requirement for nitric oxide activation of p2lras/extracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl. Acad. Sci. USA (2000) 97:436–441.
   PubMedGoogle Scholar
• SHAMLOO M, RYTTER A, WIELOCH T: Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Neuroscience (1999) 93:81–88.
   PubMedGoogle Scholar
• GU Z, JIANG Q, ZHANG G, CUI Z, ZHU Z: Diphosphorylation of extracellular signal-regulated kinases and c-Jun N-terminal protein kinases in brain ischemic tolerance in rat. Brain Res. (2000) 860:157–160.
   PubMedGoogle Scholar
• GU Z, JIANG Q, ZHANG G: Extracellular signal-regulated kinase and c-Jun N-terminal protein kinase in ischemic tolerance. Neuroreport (2001) 12:3487–3491.
   PubMed Web of Science ®Google Scholar
• CHOW AK, THOMPSON CS, HOGAN MJ, BANNER D, SOBOURIN LA, HAKIM AM: Cortical spreading depression transiently activates MAP kinases. Brain Res. MM. Brain Res. (2002) 99:75–81.
   PubMedGoogle Scholar
• JIANG Y, WU J, HUA Y et al: Thrombin-receptor activation and thrombin-induced brain tolerance. Cereb. Blood Flow Metab. (2002) 44:404–410.
   Google Scholar
• SUGINO T, NOZAKI K, HASHIMOTO N: Activation of mitogen-activated protein kinases in gerbil hippocampus with ischemic tolerance induced by 3-nitropropionic acid. Neurosci. Lett. (2000) 278:101–104.
   PubMedGoogle Scholar
• YANO S, MORIOKA M, FUKUNAGA K et al.: Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. I Cereb. Blood Flow Metab. (2001) 21:351–360.
   PubMed Web of Science ®Google Scholar
• HAYASHI T, SAITO A, OKUNO S, FERRAND-DRAKE M, CHAN PH: Induction of GRP78 by ischemic preconditioning reduces endoplasmic reticulum stress and prevents delayed neuronal cell death. Cereb. Blood Flow Metab. (2003) 23:949–961.
   PubMed Web of Science ®Google Scholar
• ABE H, NOWAK TS: Postischemic temperature as a modulator of the stress response in brain: dissociation of heat shock protein 72 induction from ischemic tolerance after bilateral carotid artery occlusion in the gerbil. Neurosci. Lett. (2000) 295:54–58.
   PubMedGoogle Scholar
• NISHI S, TAKI W, UEMURA Y et al: Ischemic tolerance due to the induction of HSP70 in a rat ischemic recirculation model. Brain Res. (1993) 615:281–288.
   PubMedGoogle Scholar
• CURRIE RW, ELLISON JA, WHITE RF, FEUERSTEIN GZ, WANG X, BARONE FC: Benign focal ischemic preconditioning induces neuronal HSP70 and prolonged astrogliosis with expression of HSP27. Brain Res. (2000) 863:169–181.
   PubMed Web of Science ®Google Scholar
• RESHEF A, CAPUA ND, SPERLING O, ZOREF-SHANI E: Ischemic tolerance conferred to cultured rat neurons by heat shock is not mediated by opening of adenosine triphosphate-sensitive potassium channels. Neurosci. Lett. (2000) 287:223–226.
   PubMedGoogle Scholar
• YU ZF, MATTSON MP: Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. Neurosci. Res. (1999) 57:830–839.
   Google Scholar
• KATO H, ARAKII T, ITOYAMA Y, KOGURE K, KATO K: An immunohistochemical study of heat shock protein-27 in the hippocampus in a gerbil model of cerebral ischemia and ischemic tolerance. Neuroscience (1995) 68:65–71.
   PubMed Web of Science ®Google Scholar
• VALENTIM LM, GEYER AB, TAVARES H et al.: Effects of global cerebral ischemia and preconditioning on heat shock protein 27 immunocontent and phosphorylation in rat hippocampus. Neuroscience (2001) 107:43–49.
   PubMed Web of Science ®Google Scholar
• TANAKA S, KITAGAWA K, OHTSUKI T et al.: Synergistic induction of HSP40 and HSC70 in the mouse hippocampal neurons after cerebral ischemia and ischemic tolerance in gerbil hippocampus. Neurosci. Res. (2002) 67:37–47.
   Google Scholar
• YAGITA Y, KITAGAWA K, OHTSUKI T, TANAKA S, HORI M, MATSUMOTO M: Induction of HSP110/105 family in the rat hippocampus in cerebral ischemia and ischemic tolerance.' Cereb. Blood Flow Metab. (2001) 21:811–819.
   PubMedGoogle Scholar
• KATO H, CHEN T, LIU XH, NAKATA N, KOGURE K: Immunohistochemical localization of ubiquitin in gerbil hippocampus with induced tolerance to ischemia. Brain Res. (1993) 619:339–343.
   PubMedGoogle Scholar
• IDE T, TAKADA K, QIU JH et al: Ubiquitin stress response in postischemic hippocampal neurons under nontolerant and tolerant conditions.' Cereb. Blood Flow Metab. (1999) 19:750–756.
   PubMedGoogle Scholar
• KO HS, UEHARA T, NOMURA Y: Role of ubiquilin associated with protein-disulfide isomerase in the endoplasmic reticulum in stress-induced apoptotic cell death.' Biol. Chem. (2002) 277:35386–35392.
   Google Scholar
• SONG Z, STELLER H: Death by design: mechanism and control of apoptosis. Trends Cell Biol (1999) 9:49–52.
   PubMed Web of Science ®Google Scholar
• ROBERTSON GS, CROCKER SJ, NICHOLSON DW, SCHULZ JB: Neuroprotection by the inhibition of apoptosis. Brain Pathol (2000) 10:283–292.
   PubMed Web of Science ®Google Scholar
• FERRER I, PLANAS AM: Signaling of cell death and cell survival following ocal cerebral ischemia: life and death struggle in the penumbra. Neuropathol Exp. Nemo]. (2003) 62:329–339.
   PubMed Web of Science ®Google Scholar
• FLOYD RA, HENSLEY K: Oxidative stress in brain aging: implications for therapeutics of neurodegenerative diseases. Neurobiol Aging (2002) 23:795–807.
   PubMed Web of Science ®Google Scholar
• PONG K: Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics. Expert Opin. Biol. Titer. (2003) 3:127–139.
   PubMed Web of Science ®Google Scholar
• FEUERSTEIN GZ, WANG X, BARONE FC: Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann. NY Acad. Sci. (1997) 15:179–193.
   Google Scholar
• FEUERSTEIN GZ, WANG X, BARONE FC: The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation (1998) 5:143–159.
   PubMed Web of Science ®Google Scholar
• DEL ZOPPO G, GINIS I, HALLEN BECK JM, IADECOLA C, WANG X, FEUERSTEIN GZ: Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol (2000) 10:95–112.
   PubMed Web of Science ®Google Scholar
• DEL ZOPPO G, BECKER KJ, HALLENBECK JM: Inflammation after stroke: is it harmful? Arch. Neurol (2001) 58:669–672.
   Google Scholar
• ••An excellent overview of inflammationafter stroke.
   Google Scholar
• CLARK WM, LUTSEP HL: Potential of anticytokine therapies in central nervous system ischemia. Expert Opin. Biol. The]: (2001) 1:227–237.
   PubMed Web of Science ®Google Scholar
• EMSLEY HC, TYRRELL PJ: Inflammation and infection in clinical stroke. I Cereb. Blood Flow Metab. (2002) 22:1399–1419.
   PubMed Web of Science ®Google Scholar
• HALLENBECK JM: The many faces of tumor necrosis factor in stroke. Nat. Med. (2002) 8:1363–1368.
   PubMed Web of Science ®Google Scholar
• ••An excellent overview of TNF-a in stroke.
   Google Scholar
• WYSS-CORAY T, MUCKE L: Inflammation in neurodegenerative disease - a double-edged sword. Neuron (2002) 35:419–432.
   PubMed Web of Science ®Google Scholar
• DICHTER MA, LOCKE RE: Clinical trials in neuroprotection. Expert Opin. Emerg. Drugs (2003) 8:267–271.
   PubMedGoogle Scholar
• LEGOS JJ, TUMA RF, BARONE FC: Pharmacological interventions for stroke: failures and future. Expert Opin. Investig. Drugs (2002) 11:603–614.
   PubMed Web of Science ®Google Scholar
• WEGENER S, GOTTSCHALK B, JOVANOVIC V et al.: Transient ischemic attacks before ischemic stroke: preconditioning the human brain? Stroke (2004) 35:616–621.
   Google Scholar
• ••An excellent clinical demonstration of theneuroprotective effects of TIAs on subsequent ischaemic attacks in the human brain.
   Google Scholar
• ABBRACCHIO MP, CATTABENI F: Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases. Ann. NY Acad. Sri (1999) 890:79–92.
   PubMed Web of Science ®Google Scholar
• ••An excellent overview of adenosine receptors as therapeutic targets in the treatment of neurodegenerative diseases.
   Google Scholar
• SZEWCZYK A, MARBAN E: Mitochondria: a new target for K.' channel openers? Trends Pharmacol Sci. (1999) 20:157–161.
   PubMed Web of Science ®Google Scholar
• MATTSON MP, LIU D: Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death. Biochem. Biophys. Res. Commun. (2003) 304:539–549.
   PubMed Web of Science ®Google Scholar
• HEALES SJ, BOLANOS JP, STEWART VC, BROOKES PS, LAND JM: Nitric oxide, mitochondria, and neurological disease. Biochim. Biophys. Acta (1999) 9:215–228.
   Google Scholar
• MATTSON MP, CULMSEE C, YU ZF: Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res. (2000) 301:173–187.
   PubMed Web of Science ®Google Scholar
• FRIBERG H, WIELOCH T: Mitochondrial permeability transition in acute neurodegeneration. Biochimie (2002) 84:241–450.
   PubMedGoogle Scholar
• RAO AV, BALACHANDRAN B: Role of oxidative stress and antioxidants in neurodegenerative diseases. Num. Neurosci. (2002) 5:291–309.
   PubMed Web of Science ®Google Scholar
• BARONE FC, IRVING EA, RAY AM et al: Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev (2001) 21:129–145.
   PubMed Web of Science ®Google Scholar
• HARPER SJ, WILKIE N: MAPKs: new targets for neurodegeneration. Expert Opin. Ther. Targets (2003) 7:187–200.
   PubMed Web of Science ®Google Scholar
• SKAPER SD, WALSH FS: Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration. MM. Cell. Neurosci. (1998) 12:179–193.
   PubMed Web of Science ®Google Scholar
• SEMKOVA I, KRIEGLSTEIN J: Neuroprotection mediated via neurotrophic factors: and induction of neurotrophic factors. Brain Res. Rev. (1999) 30:176–188.
   PubMed Web of Science ®Google Scholar
• XIE Y, LONGO FM: Neurotrophin small-molecule mimetics. Frog. Brain Res. (2000) 128:333–347.
   PubMed Web of Science ®Google Scholar
• ABE K: Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. Cereb. Blood Dow Metab. (2000) 20:1393–1408.
   PubMed Web of Science ®Google Scholar
• POLLACK SJ, HARPER SJ: Small molecule trk receptor agonists and other neurotrophic factor mimetics. Carr. Drag Target. CNS Neara DiSOrd. (2002) 1:59–80.
   PubMedGoogle Scholar
• PARDRIDGE WM: Neurotrophins, neuroprotection and blood-brain barrier. Curt: Opin. Investig. Drugs (2002) 3:1753–1757.
   PubMedGoogle Scholar
• OVBIAGELE B, KIDWELL CS, STARKMAN S, SAVER JL: Neuroprotective agents for the treatment of acute ischemic stroke. Curc Neurol. Neurosci. Rep. (2003) 3:9–20.
   PubMedGoogle Scholar
• CAIRNS K, FINKLESTEIN SP: Growth factors and stem cells and treatments for stroke recovery. Phys. Med. Rehab:a. Clin. N Am. (2003) 14:S135–S142.
   Google Scholar
• DAWBARN D, ALLEN SJ: Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol (2003) 29:211–230.
   PubMed Web of Science ®Google Scholar
• SIREN AL, EHRENREICH H: Erythropoietin: a novel concept for neuroprotection. Eur. Arch. Psychiatry Clin. Neurosci. (2001) 251:179–184.
   PubMed Web of Science ®Google Scholar
• DAWSON TM: Preconditioning-mediated neuroprotection through erythropoietin? Lancet (2002) 359:96–97.
   PubMedGoogle Scholar
• CERAMI A, BRINES M, GHEZZI P, CERAMI C, ITRI LM: Neuroprotective properties of epoetin alfa. Nephrol. Dial. Transplant. (2002) 17:8–12.
   PubMed Web of Science ®Google Scholar
• BRINES M: What evidence supports use of erythropoietin as a novel neurotherapeutic? Oncology (Duntingt) (2002) 16:79–89.
   PubMedGoogle Scholar
• EID T, BRINES M: Recombinant human erythropoietin for neuroprotection. What is the evidence? Clin. Breast Cancer (2002) 3:S109–S115.
   Google Scholar
• TATSUNO I, MORIO H, TANAKA T et al.: Pituitary adenylate cyclase-activating polypeptide (PACAP) is a regulator of astrocytes: PACAP stimulates proliferation and production of interleukin 6 (IL-6), but not nerve growth factor (NGF), in cultured rat astrocytes. Ann. NY Acad. Sci. (1996) 805:482–488.
   PubMedGoogle Scholar
• TUSZYNSKI MH: Gene therapy for neurological disease. Expert Opin. Biol. Ther. (2003) 3:815–828.
   PubMed Web of Science ®Google Scholar
• BREWER GJ: Neuronal plasticity and stressor toxicity during aging. Exp. Cerontol. (2000) 35:1165–1183.
   PubMedGoogle Scholar
• VILLABLANCA JR, HOVDA DA: Developmental neuroplasticity in a model of cerebral hemispherectomy and stroke. Neuroscience (2000) 95:625–637.
   PubMedGoogle Scholar
• CARMICHAEL ST: Plasticity of cortical projections after stroke. Neuroscientist (2003) 9:64–75.
   PubMed Web of Science ®Google Scholar
• HALLETT M: Plasticity of the human motor cortex and recovery from stroke. Brain Res. Rev (2001) 36:169–174.
   PubMed Web of Science ®Google Scholar
• HARVEY RL, CHOPP M: The therapeutic effects of cellular therapy for functional recovery after brain injury. Phys. Med. Rehab:a. Clin. N Am. (2003) 14:143–151.
   PubMedGoogle Scholar
• CHEN R, COHEN LG, HALLETT M: Nervous system reorganization following injury. Neuroscience (2002) 111:761–777.
   PubMed Web of Science ®Google Scholar
• KITAGAWA K, MATSUMOTO M, HORI M: Protective and regenerative response endogenously induced in the ischemic brain. Can. .1 Physial Pharmacol (2001) 79:262–265.
   PubMedGoogle Scholar
• CHOPP M, LI Y: Treatment of neural injury with stromal cells. Lancet Neurol. (2002) 1:92–100.
   PubMed Web of Science ®Google Scholar
• MOSKOWITZ M, LO EH: Neurogenesis and apoptotic cell death. Stroke (2003) 34:324–326.
   PubMed Web of Science ®Google Scholar
• FELLING RJ, LEVISON SW: Enhanced neurogenesis following stroke. NeuroscL Res. (2003) 73:277–283.
   Google Scholar
• SCHWAB ME: Increasing plasticity and functional recovery of the lesioned spinal cord. Frog. Brain Res. (2002) 137:351–359.
   PubMedGoogle Scholar
• HUNT D, COFFIN RS, ANDERSON PN: The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review. .1 Neurocyta (2002) 31:93–120.
   PubMedGoogle Scholar
• MCKERRACHER L, WINTON MJ: Nogo on the go. Neuron (2002) 36:345–348.
   PubMed Web of Science ®Google Scholar
• BANDTLOW CE: Regeneration in the central nervous system. Exp. Cerontol. (2003) 38:79–86.
   PubMed Web of Science ®Google Scholar
• PAPADOPOULOS CM, TSAI SY, ALSBIEI T et al.: Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann. Neurol. (2002) 51:433–441.
   PubMed Web of Science ®Google Scholar
• WIESSNER C, BAREYRE FM, ALLEGRINI PR et al.: Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. Cereb. Blood Dow Metab. (2003) 23:154–165.
   PubMed Web of Science ®Google Scholar